Baby Detect : Genomic Newborn Screening

Plain-language summary

This study evaluated a genomic newborn screening method aimed at the early detection of genetic diseases in newborns. It enrolled babies within the first 28 days after birth, with their parents' consent. It was a trial without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Centre Hospitalier Universitaire de Liege

Start date

9/1/2022

Estimated completion

6/2/2025

Countries

Belgium

Related genes

Locations

• Liège, Belgium

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* newborn between birth and 28 days of life
* consent of parent

Exclusion Criteria:

* \+ 28 days
* Non consent of parent